Armistice Capital, LLC Mirati Therapeutics, Inc. Transaction History

Armistice Capital, LLC

$6.02 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$41.99 - $62.38 $36.3 Million - $53.9 Million	-864,098 Reduced 63.35%	500,000 $29.4 Million
Q3 2023 Nov 14, 2023	SELL	$27.8 - $45.35 $72.7 Million - $119 Million	-2,613,902 Reduced 65.71%	1,364,098 $59.4 Million
Q2 2023 Aug 14, 2023	BUY	$36.13 - $49.49 $10.3 Million - $14.2 Million	286,000 Added 7.75%	3,978,000 $144 Million
Q1 2023 May 15, 2023	BUY	$36.54 - $54.26 $7.45 Million - $11.1 Million	204,000 Added 5.85%	3,692,000 $137 Million
Q4 2022 Feb 14, 2023	BUY	$41.27 - $98.62 $65.5 Million - $157 Million	1,588,000 Added 83.58%	3,488,000 $158 Million
Q3 2022 Nov 14, 2022	SELL	$59.5 - $86.7 $8.81 Million - $12.8 Million	-148,000 Reduced 7.23%	1,900,000 $133 Million
Q2 2022 Aug 15, 2022	BUY	$39.16 - $88.71 $26.8 Million - $60.7 Million	684,000 Added 50.15%	2,048,000 $137 Million
Q1 2022 May 16, 2022	BUY	$75.82 - $150.97 $40 Million - $79.7 Million	528,000 Added 63.16%	1,364,000 $112 Million
Q4 2021 Feb 14, 2022	BUY	$132.01 - $190.29 $16.6 Million - $24 Million	126,000 Added 17.75%	836,000 $123 Million
Q3 2021 Nov 15, 2021	BUY	$132.13 - $177.45 $6.61 Million - $8.87 Million	50,000 Added 7.58%	710,000 $126 Million
Q2 2021 Aug 16, 2021	BUY	$144.0 - $179.73 $17.9 Million - $22.3 Million	124,000 Added 23.13%	660,000 $107 Million
Q1 2021 May 17, 2021	BUY	$158.92 - $221.61 $42 Million - $58.5 Million	264,000 Added 97.06%	536,000 $91.8 Million
Q4 2020 Feb 16, 2021	BUY	$162.05 - $240.27 $16.9 Million - $25 Million	104,000 Added 61.9%	272,000 $59.7 Million
Q3 2020 Nov 16, 2020	SELL	$113.26 - $167.27 $11.8 Million - $17.4 Million	-104,000 Reduced 38.24%	168,000 $27.9 Million
Q2 2020 Aug 14, 2020	SELL	$72.01 - $120.39 $2.88 Million - $4.82 Million	-40,000 Reduced 12.82%	272,000 $31.1 Million
Q1 2020 May 15, 2020	BUY	$69.78 - $116.21 $13.4 Million - $22.3 Million	192,000 Added 160.0%	312,000 $24 Million
Q4 2019 Feb 14, 2020	BUY	$70.76 - $128.86 $8.49 Million - $15.5 Million	120,000 New	120,000 $15.5 Million

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Armistice Capital, LLC with notifications on news.

Account